Edwards Lifesciences Corporation (EW)
NYSE · Healthcare
Edwards Lifesciences Corporation Shareholder Equity 2008–2025
Edwards Lifesciences Corporation annual shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Edwards Lifesciences Corporation shareholder equity as of December 31, 2025: 10.34B, a 3.39% increase year-over-year.
- Edwards Lifesciences Corporation shareholder equity for 2025 were 10.34B, a 3.39% increase from 2024.
- Edwards Lifesciences Corporation shareholder equity for 2024 were 10.00B, a 50.35% increase from 2023.
- Edwards Lifesciences Corporation shareholder equity for 2023 were 6.65B, a 14.52% increase from 2022.
- Edwards Lifesciences Corporation shareholder equity for 2022 were 5.81B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Edwards Lifesciences Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $10,338 |
| 2024 | $9,998 |
| 2023 | $6,650 |
| 2022 | $5,807 |
| 2021 | $5,836 |
| 2020 | $4,574 |
| 2019 | $4,148 |
| 2018 | $3,140 |
| 2017 | $2,956 |
| 2016 | $2,619 |
| 2015 | $2,503 |
| 2014 | $2,191 |
| 2013 | $1,544 |
| 2012 | $1,467 |
| 2011 | $1,327 |
Edwards Lifesciences Corporation Shareholder Equity — FAQ
Edwards Lifesciences Corporation (EW) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EW's shareholder equity history?
The chart and table above show Edwards Lifesciences Corporation's shareholder equity by year and by quarter, including the growth rate.